Case Report
BibTex RIS Cite
Year 2019, Volume: 1 Issue: 3, 126 - 130, 31.12.2019

Abstract

References

  • 1) Gao QY, Fu Y, Hui YN. Vitreous substitutes: challenges and directions. International journal of ophthalmology. 2015;8(3):437.
  • 2) Lin X, Wang Z, Jiang Z, Long C, Liu Y, Wang P, Jin C, Yi C, Gao Q. Preliminary Efficacy And Safety Of A Silicone Oil–filled Foldable Capsular Vitreous Body In The Treatment Of Severe Retinal Detachment. Retina. 2012 Apr 1;32(4):729-41.
  • 3) Maruoka, S. et al. Biocompatibility of polyvinylalcohol gel as a vitreous substitute. Curr Eye Res. 31, 599–606 (2006).
  • 4) Kleinberg, T. T., Tzekov, R. T., Stein, L., Ravi, N. & Kaushal, S.Vitreous substitutes: a comprehensive review. Surv Ophthalmol.56, 300–323 (2011).
  • 5) Swindle-Reilly, K. E. et al. Rabbit study of an in situ forming hydrogel vitreous substitute. Invest Ophthalmol Vis Sci. 50, 4840–4846 (2009).
  • 6) Federman, J. L. & Schubert, H. D. Complications associated with the use of silicone oil in 150 eyes after retina-vitreous surgery. Ophthalmology. 95, 870–876 (1988).
  • 7) Valone Jr, J. & McCarthy, M. Emulsified anterior chamber silicone oil and glaucoma. Ophthalmology. 101, 1908–1912 (1994).
  • 8) Ichhpujani, P., Jindal, A. & Jay Katz, L. Silicone oil induced glaucoma: a review. Graefes Arch Clin Exp Ophthalmol. 247, 1585–1593 (2009).
  • 9) Foster, W. J. Vitreous Substitutes. Expert Rev Ophthalmol 3, 211–218 (2008).
  • 10) Li, W. et al. Clinical complications of Densiron 68 intraocular tamponade for complicated retinal detachment. Eye (Lond). 24, 21–28 (2010).
  • 11) Stefansson, E., Anderson, M. M., Jr, Landers, M. B., III, Tiedeman, J. S. & McCuen, B. W., II Refractive changes from use of silicone oil in vitreous surgery. Retina. 8, 20–23 (1988).
  • 12) Kleinberg, T. T., Tzekov, R. T., Stein, L., Ravi, N. & Kaushal, S.Vitreous substitutes: a comprehensive review. Surv Ophthalmol.56, 300–323 (2011).
  • 13) Baino, F. Towards an ideal biomaterial for vitreous replacement: Historical overview and future trends. Acta Biomater. 7, 921–935 (2011).
  • 14) Pastor, J. C. Proliferative vitreoretinopathy: an overview. Surv Ophthalmol. 43, 3–18 (1998).
  • 15) Leone, G. et al. PVA/STMP based hydrogels as potential substitutes of human vitreous. J Mater Sci Mater Med. 21, 2491–2500 (2010).
  • 16) Maruoka, S. et al. Biocompatibility of polyvinylalcohol gel as a vitreous substitute. Curr Eye Res. 31, 599–606 (2006).
  • 17) Wang, P. et al. Biocompatibility and retinal support of a foldable capsular vitreous body injected with saline or silicone oil implanted in rabbit eyes. Clin Experiment Ophthalmol. 40, e67–75 (2012).
  • 18) Chen, J. et al. Clinical device-related article evaluation of morphology and functions of a foldable capsular vitreous body in the rabbit eye. J Biomed Mater Res B Appl Biomater. 97, 396–404 (2011).
  • 19) Maruoka, S. et al. Biocompatibility of polyvinylalcohol gel as a vitreous substitute. Curr Eye Res. 31, 599–606 (2006).
  • 20) Hara, Y. et al. Biocompatibility of polyvinylalcohol gel as a vitreous substitute. Nihon Ganka Gakkai Zasshi. 102, 247–255 (1998).
  • 21) Jiang, Z. et al. Evaluation of the levofloxacin release characters from a rabbit foldable capsular vitreous body. Int J Nanomedicine.7, 1–10 (2012).
  • 22) Jiang, Z. et al. Evaluation of levofloxacin release characteristics from a human foldable capsular vitreous body in vitro. J Ocul Pharmacol Ther. 28, 33–40 (2012).
  • 23) Liu, Y. et al. Sustained mechanical release of dexamethasone sodium phosphate from a foldable capsular vitreous body. Invest Ophthalmol Vis Sci. 51, 1636–1642 (2010).
  • 24) Zheng, H. et al. Evaluation of 5-fluorouracil released from a foldable capsular vitreous body in vitro and in vivo. Graefes Arch Clin Exp Ophthalmol. 250, 751-759 (2012).
  • 25) Chen, X. et al. Protein kinase Calpha downregulation via siRNA-PKCalpha released from foldable capsular vitreous body in cultured human retinal pigment epithelium cells. Int J Nanomedicine. 6, 1303–1311 (2011).

Foldable Capsular Vitreous Body implant for post-traumatic Phthisical Eye: A Case Report

Year 2019, Volume: 1 Issue: 3, 126 - 130, 31.12.2019

Abstract

Abstract



Purpose:
To analyze the outcomes of foldable capsular vitreous body injected in a
post-traumatic phthysical eye.



Case
presentation: A 19 year old male patient presented to ophthalmology department
with left post-traumatic phthisical eye , who had previously undergone
corneoscleral tear repair due to a penetrating trauma to his left eye one year
back. On ocular examination , there is a corneo scleral scar mark, aniridia ,
aphakia and retina incarcerated in the scar. He was injected with a foldable
capuslar vitreous body.



Conclusion:
Our case report of foldable capsular vitreous body gives an excellent cosmesis
for the physical eye.

References

  • 1) Gao QY, Fu Y, Hui YN. Vitreous substitutes: challenges and directions. International journal of ophthalmology. 2015;8(3):437.
  • 2) Lin X, Wang Z, Jiang Z, Long C, Liu Y, Wang P, Jin C, Yi C, Gao Q. Preliminary Efficacy And Safety Of A Silicone Oil–filled Foldable Capsular Vitreous Body In The Treatment Of Severe Retinal Detachment. Retina. 2012 Apr 1;32(4):729-41.
  • 3) Maruoka, S. et al. Biocompatibility of polyvinylalcohol gel as a vitreous substitute. Curr Eye Res. 31, 599–606 (2006).
  • 4) Kleinberg, T. T., Tzekov, R. T., Stein, L., Ravi, N. & Kaushal, S.Vitreous substitutes: a comprehensive review. Surv Ophthalmol.56, 300–323 (2011).
  • 5) Swindle-Reilly, K. E. et al. Rabbit study of an in situ forming hydrogel vitreous substitute. Invest Ophthalmol Vis Sci. 50, 4840–4846 (2009).
  • 6) Federman, J. L. & Schubert, H. D. Complications associated with the use of silicone oil in 150 eyes after retina-vitreous surgery. Ophthalmology. 95, 870–876 (1988).
  • 7) Valone Jr, J. & McCarthy, M. Emulsified anterior chamber silicone oil and glaucoma. Ophthalmology. 101, 1908–1912 (1994).
  • 8) Ichhpujani, P., Jindal, A. & Jay Katz, L. Silicone oil induced glaucoma: a review. Graefes Arch Clin Exp Ophthalmol. 247, 1585–1593 (2009).
  • 9) Foster, W. J. Vitreous Substitutes. Expert Rev Ophthalmol 3, 211–218 (2008).
  • 10) Li, W. et al. Clinical complications of Densiron 68 intraocular tamponade for complicated retinal detachment. Eye (Lond). 24, 21–28 (2010).
  • 11) Stefansson, E., Anderson, M. M., Jr, Landers, M. B., III, Tiedeman, J. S. & McCuen, B. W., II Refractive changes from use of silicone oil in vitreous surgery. Retina. 8, 20–23 (1988).
  • 12) Kleinberg, T. T., Tzekov, R. T., Stein, L., Ravi, N. & Kaushal, S.Vitreous substitutes: a comprehensive review. Surv Ophthalmol.56, 300–323 (2011).
  • 13) Baino, F. Towards an ideal biomaterial for vitreous replacement: Historical overview and future trends. Acta Biomater. 7, 921–935 (2011).
  • 14) Pastor, J. C. Proliferative vitreoretinopathy: an overview. Surv Ophthalmol. 43, 3–18 (1998).
  • 15) Leone, G. et al. PVA/STMP based hydrogels as potential substitutes of human vitreous. J Mater Sci Mater Med. 21, 2491–2500 (2010).
  • 16) Maruoka, S. et al. Biocompatibility of polyvinylalcohol gel as a vitreous substitute. Curr Eye Res. 31, 599–606 (2006).
  • 17) Wang, P. et al. Biocompatibility and retinal support of a foldable capsular vitreous body injected with saline or silicone oil implanted in rabbit eyes. Clin Experiment Ophthalmol. 40, e67–75 (2012).
  • 18) Chen, J. et al. Clinical device-related article evaluation of morphology and functions of a foldable capsular vitreous body in the rabbit eye. J Biomed Mater Res B Appl Biomater. 97, 396–404 (2011).
  • 19) Maruoka, S. et al. Biocompatibility of polyvinylalcohol gel as a vitreous substitute. Curr Eye Res. 31, 599–606 (2006).
  • 20) Hara, Y. et al. Biocompatibility of polyvinylalcohol gel as a vitreous substitute. Nihon Ganka Gakkai Zasshi. 102, 247–255 (1998).
  • 21) Jiang, Z. et al. Evaluation of the levofloxacin release characters from a rabbit foldable capsular vitreous body. Int J Nanomedicine.7, 1–10 (2012).
  • 22) Jiang, Z. et al. Evaluation of levofloxacin release characteristics from a human foldable capsular vitreous body in vitro. J Ocul Pharmacol Ther. 28, 33–40 (2012).
  • 23) Liu, Y. et al. Sustained mechanical release of dexamethasone sodium phosphate from a foldable capsular vitreous body. Invest Ophthalmol Vis Sci. 51, 1636–1642 (2010).
  • 24) Zheng, H. et al. Evaluation of 5-fluorouracil released from a foldable capsular vitreous body in vitro and in vivo. Graefes Arch Clin Exp Ophthalmol. 250, 751-759 (2012).
  • 25) Chen, X. et al. Protein kinase Calpha downregulation via siRNA-PKCalpha released from foldable capsular vitreous body in cultured human retinal pigment epithelium cells. Int J Nanomedicine. 6, 1303–1311 (2011).
There are 25 citations in total.

Details

Primary Language English
Journal Section Case Report
Authors

Hussain Ahmed Khaqan

Hasnain Muhammad Buksh

Usman Imtiaz This is me 0000-0002-8311-4059

Ateeq-ur Rehman This is me

Raheela Naz This is me

Usman Shabbir This is me

Publication Date December 31, 2019
Acceptance Date December 18, 2019
Published in Issue Year 2019 Volume: 1 Issue: 3

Cite

APA Ahmed Khaqan, H., Buksh, H. M., Imtiaz, U., Rehman, A.-u., et al. (2019). Foldable Capsular Vitreous Body implant for post-traumatic Phthisical Eye: A Case Report. Clinical and Experimental Ocular Trauma and Infection, 1(3), 126-130.
AMA Ahmed Khaqan H, Buksh HM, Imtiaz U, Rehman Au, Naz R, Shabbir U. Foldable Capsular Vitreous Body implant for post-traumatic Phthisical Eye: A Case Report. CEOTI. December 2019;1(3):126-130.
Chicago Ahmed Khaqan, Hussain, Hasnain Muhammad Buksh, Usman Imtiaz, Ateeq-ur Rehman, Raheela Naz, and Usman Shabbir. “Foldable Capsular Vitreous Body Implant for Post-Traumatic Phthisical Eye: A Case Report”. Clinical and Experimental Ocular Trauma and Infection 1, no. 3 (December 2019): 126-30.
EndNote Ahmed Khaqan H, Buksh HM, Imtiaz U, Rehman A-u, Naz R, Shabbir U (December 1, 2019) Foldable Capsular Vitreous Body implant for post-traumatic Phthisical Eye: A Case Report. Clinical and Experimental Ocular Trauma and Infection 1 3 126–130.
IEEE H. Ahmed Khaqan, H. M. Buksh, U. Imtiaz, A.-u. Rehman, R. Naz, and U. Shabbir, “Foldable Capsular Vitreous Body implant for post-traumatic Phthisical Eye: A Case Report”, CEOTI, vol. 1, no. 3, pp. 126–130, 2019.
ISNAD Ahmed Khaqan, Hussain et al. “Foldable Capsular Vitreous Body Implant for Post-Traumatic Phthisical Eye: A Case Report”. Clinical and Experimental Ocular Trauma and Infection 1/3 (December 2019), 126-130.
JAMA Ahmed Khaqan H, Buksh HM, Imtiaz U, Rehman A-u, Naz R, Shabbir U. Foldable Capsular Vitreous Body implant for post-traumatic Phthisical Eye: A Case Report. CEOTI. 2019;1:126–130.
MLA Ahmed Khaqan, Hussain et al. “Foldable Capsular Vitreous Body Implant for Post-Traumatic Phthisical Eye: A Case Report”. Clinical and Experimental Ocular Trauma and Infection, vol. 1, no. 3, 2019, pp. 126-30.
Vancouver Ahmed Khaqan H, Buksh HM, Imtiaz U, Rehman A-u, Naz R, Shabbir U. Foldable Capsular Vitreous Body implant for post-traumatic Phthisical Eye: A Case Report. CEOTI. 2019;1(3):126-30.